Abstract
Aberrant signaling through G‐protein coupled receptors promotes metastasis, the major cause of breast cancer death. We identified Regulator of G‐protein Signaling 4 (RGS4) as a novel metastasis suppressor. By blocking signals initiated through Gi‐coupled receptors, such as protease‐activated receptor 1 and CXC chemokine receptor 4, via its GTPase Activating Protein (GAP) activity, RGS4 disrupted Rac1‐dependent lamellipodia formation, a key step involved in metastasis. An RGS4 GAP‐deficient mutant failed to inhibit the metastatic abilities of breast cancer cells in both in vitro and a mouse xenograft model. Interestingly, both established breast cancer cell lines and human breast cancer specimens showed that the highest levels of RGS4 protein were expressed in normal breast epithelia and that RGS4 down‐regulation by proteasome degradation is an index of breast cancer metastasis. Proteasome blockade increases endogenous RGS4 protein to levels that markedly inhibit breast cancer cell migration and invasion, which could be reversed by an RGS4‐targeted shRNA. Our findings point to the existence of a mechanism for posttranslational regulation of RGS4 function, which may have important implications for the acquisition of a metastatic phenotype by breast cancer. Preventing RGS4 degradation should retard the spread of breast cancer cells and making them targets for surgery, radiation and immune treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.